AbbVie Inc. Share Repurchase Authorization
AbbVie Inc. (ABBV) had Share Repurchase Authorization of $10.00 billion as of 2018-02-15, per its 10-Q filed 2018-08-07.
Discontinued › Notes › Equity
us-gaap:StockRepurchaseProgramAuthorizedAmount1 · last filed 2018-08-07
- 2018-02-15: Stock Repurchase Program, Authorized Amount $10.00B.
- 2017-02-16: Stock Repurchase Program, Authorized Amount $5.00B.
- 2015-03-31: Stock Repurchase Program, Authorized Amount $5.00B.
- 2014-10-20: Stock Repurchase Program, Authorized Amount $5.00B.
| Period end | Stock Repurchase Program, Authorized Amount |
|---|---|
| 2018-02-15 | $10.00B 10-Q · filed 2018-08-07 |
| 2017-02-16 | $5.00B 10-Q · filed 2017-11-07 |
| 2015-03-31 | $5.00B 10-Q · filed 2016-08-05 |
| 2014-10-20 | $5.00B 10-Q · filed 2016-08-05 |
| 2013-02-15 | $1.50B 10-K · filed 2016-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |